Allergic rhinitis prevention with specific

Allergic rhinitis with a 20% incidence which is constantly increasing in relation to environmental (smog, cigarette smoke) and climatic factors is today considered a systemic disease with the nose as the shock organ [1], This trend has, consequently, resulted in an increase in social and economic expenditure on the disease arousing interest in prevention and, particularly, in specific immunosensitizing therapy administered subcutaneously or locally [2],... 

The results of this clinical study using rhuMAb-E25 to prevent symptoms of birch allergic rhinitis mirrored the result of the preceding study in ragweed-induced SAR. Together, these studies demonstrate and confirm the therapeutic benefit of anti-IgE in SAR. Furthermore, since anti-IgE therapy is not allergen-specific, this therapeutic approach likely will benefit allergic patients with multiple sensitivities. 

---